The company officially launched new production suites, a revamp of its development labs, and more at its Thousand Oaks, Calif., cell therapy manufacturing facility.

Pii Invests $3.6 Million to Boost Prefilled Syringe Capabilities

By Nicholas Saraceno

November 22nd 2024

With this $3.6 million investment, the CDMO will strengthen its advanced labeling, automated visual inspection, and fill/finish technology.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Sanofi Invests €40 Million to Boost Antibody Production in France

By Feliza Mirasol

November 21st 2024

The investment will allow Sanofi to strengthen antibody bioproduction at its Lyon Gerland site in France.

Circio Forms Collaboration with Certest to Develop LNP Formulations

By Feliza Mirasol

November 20th 2024

Under the collaboration, the companies will create and test circVec DNA–LNP formulations with an eye toward potential therapeutic applications.

SEKISUI Completes CDMO Capacity Expansion for CGMP Biopharma Manufacturing

By Feliza Mirasol

November 19th 2024

Under a £15.7 million (US$20.7 million) investment, SEKISUI has expanded its UK site for clinical-grade drug substance manufacturing.

...

45 46 47 48 49

About Us

Advertise

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777